Abstract
Purified precursor Hageman factor has been demonstrated to bind to soluble bacterial lipopolysaccharide (LPS, endotoxin) isolated from Escherichia coli 0111:B4, and this complex has been shown to have the capacity to convert prekallikrein to its active form. In addition, LPS-activated Hageman factor substantially reduces clotting times in XII-deficient plasma. The capacity to activate Hageman factor has been demonstrated to reside in the lipid A region of the LPS molecule. Activation of Hageman factor by LPS contrasts with fluid-phase activation (e.g., by kallikrein or trypsin) in that no cleavage to lower molecular weight fragments occurs. High concentrations of LPS inhibit the activity of Hageman factor, probably by a direct LPS-Hageman factor interaction.
Dates
Type | When |
---|---|
Created | 21 years, 2 months ago (June 23, 2004, 7:23 p.m.) |
Deposited | 2 years, 1 month ago (July 24, 2023, 6:26 p.m.) |
Indexed | 2 weeks, 5 days ago (Aug. 7, 2025, 4:49 p.m.) |
Issued | 50 years, 11 months ago (Sept. 1, 1974) |
Published | 50 years, 11 months ago (Sept. 1, 1974) |
Published Online | 50 years, 11 months ago (Sept. 1, 1974) |
Published Print | 50 years, 11 months ago (Sept. 1, 1974) |
@article{Morrison_1974, title={DIRECT EVIDENCE FOR HAGEMAN FACTOR (FACTOR XII) ACTIVATION BY BACTERIAL LIPOPOLYSACCHARIDES (ENDOTOXINS)}, volume={140}, ISSN={0022-1007}, url={http://dx.doi.org/10.1084/jem.140.3.797}, DOI={10.1084/jem.140.3.797}, number={3}, journal={The Journal of Experimental Medicine}, publisher={Rockefeller University Press}, author={Morrison, David C. and Cochrane, Charles G.}, year={1974}, month=sep, pages={797–811} }